Bioengineered skin cells hold promise for hypertension

01/16/2010 | Yahoo!

U.S. and German scientists were able to control blood pressure in mice that were fed a normal or high-salt diet using bioengineered skin cells that make atrial natriuretic peptide, a molecule responsible for lowering blood pressure. They developed the biotech cells, which were applied as skin grafts, using a retrovirus containing an RNA that produces the peptide and a marker.

View Full Article in:


Published in Brief: